デフォルト表紙
市場調査レポート
商品コード
1468526

透析市場レポート:タイプ、製品・サービス、エンドユーザー、地域別、2024~2032年

Dialysis Market Report by Type (Hemodialysis, Peritoneal Dialysis), Product and Services (Services, Equipment, Consumables, Dialysis Drugs), End User (In-center Dialysis, Home Dialysis), and Region 2024-2032

出版日: | 発行: IMARC | ページ情報: 英文 138 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=154.64円
透析市場レポート:タイプ、製品・サービス、エンドユーザー、地域別、2024~2032年
出版日: 2024年04月08日
発行: IMARC
ページ情報: 英文 138 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の透析市場規模は2023年に1,158億米ドルに達しました。今後、IMARC Groupは、2024~2032年の成長率(CAGR)は4.3%で、2032年には1,704億米ドルに達すると予測しています。透析治療に対する償還政策の利用可能性の増加、術後透析を必要とする腎移植患者の増加、腎疾患の早期診断と介入への注目の高まりなどが、市場を推進している要因の一部です。

透析は、腎臓が自然に機能しなくなった患者のための重要な腎代替療法です。この医療処置は、患者の血流から毒素、余分な水分、塩分、溶質を除去し、より健康的なバランスを効果的に回復させるという重要な役割を担っています。透析の主要目的は、血液を浄化し、体内の適切な電解質レベルを回復することです。この治療には、主に血液透析と腹膜透析の2種類があります。血液透析では、体外で血液を浄化します。この方法は血液中の不純物を効果的に取り除き、患者さんが安定した状態を取り戻すのに役立ちます。一方、腹膜透析は腹膜という腹部の内膜を利用して血液を浄化します。腹膜を透析媒体として利用することで、血液浄化に体内からアプローチする方法です。血液透析も腹膜透析も、腎臓に関連するさまざまな疾患の治療に役立ちます。これらの治療は、急性腎障害への対応、慢性腎疾患の管理、腎移植のサポート、あるいは移植が実行不可能な場合の恒久的な解決策として一般的に行われています。透析は、腎機能障害と闘う人々の生活の質を著しく向上させるものであり、その重要性はいくら強調してもしすぎることはないです。慎重な実施と医療技術の継続的な進歩により、透析は腎臓のサポートが必要な患者のライフラインとしての役割を果たし続けています。

世界市場の主要原動力は、慢性腎臓病の有病率の増加です。これに伴い、腎臓関連の問題を抱えやすい高齢化人口の増加が市場に大きく寄与しています。さらに、腎臓の健康や利用可能な治療オプションに関する意識の高まりが、市場にプラスの影響を与えています。これとは別に、より効率的な透析方法につながる急速な技術進歩が、市場に多くの機会をもたらしています。さらに、革新的な透析技術の研究開発への多額の投資が市場を活性化しています。さらに、腎臓病の主要原因である糖尿病の罹患率の増加が、透析の需要を促進しています。さらに、新興国市場における医療インフラの拡充も市場を後押ししています。在宅透析ソリューションに対する需要の高まりが市場を強化しています。

透析市場の動向と促進要因:

ライフスタイルの変化による腎臓合併症の増加

ライフスタイルの変化が市場を刺激しています。食生活の乱れ、座りっぱなしの日常生活、高いストレスレベルを特徴とする現代のライフスタイルは、腎臓合併症の増加に寄与しています。加工食品の多い不健康な食生活、高塩分、水分補給不足は、腎臓病の主要原因である高血圧や糖尿病などの慢性疾患につながる可能性があります。生活習慣要因と腎臓合併症の相関関係は、慢性腎臓病の有病率の上昇を促しています。このような腎臓に関連する問題の増加により、透析治療の需要が増加しています。患者層の拡大が透析サービスの拡大を必要とし、透析市場の成長をさらに促進しています。その結果、医療プロバイダー、医療機器メーカー、研究開発は、この需要の拡大に対応し、効果的な透析治療を提供するための革新的なソリューションや戦略を開発することに意欲を燃やしています。

民間透析クリニックセンターの拡大

民間透析クリニックや透析センターの拡大が市場を強化しています。これらの民間施設には、市場拡大に影響を与えるいくつかの重要な利点があります。民間透析施設では、患者一人ひとりのニーズに合わせた専門的で個別化された治療が提供されることが多いです。このようなレベルのカスタマイズは、患者の満足度と治療成績を向上させ、より多くの顧客を惹きつけ、市場の需要を押し上げます。さらに、私立の透析センターは、患者の好みや日課に合わせて、より柔軟なスケジューリングオプションを提供する傾向があります。この利便性が、多忙なライフスタイルに合った治療を求める人々を惹きつけています。さらに、民間クリニックの設立は、市場内の健全な競争を促進します。この競争は、治療手法、技術導入、患者サービスの革新を促し、最終的には業界全体の医療の質の向上につながります。さらに、民間施設には最新の透析機器、技術、熟練した医療従事者が揃っていることが多く、効率的で効果的な治療が保証されます。このような高水準の医療は、患者や紹介元医師の信頼構築に役立ち、患者紹介と市場成長をさらに促進します。民間透析クリニックは、透析サービスを求める患者に別の選択肢を提供することで、公的医療システムの負担軽減に貢献しています。この側面は、公的資源が限られている地域では特に重要であり、民間透析センターは医療インフラの負担を軽減することができるからです。

持続的外来腹膜透析(CAPD)と自動腹膜透析(APD)の需要増加

持続的外来腹膜透析(CAPD)と自動腹膜透析(APD)の需要の高まりが、市場の成長を促進しています。これらの先進的な腹膜透析技術には多くの利点があり、人気の高まりにつながっています。CAPDとAPDは、従来の施設内血液透析よりも柔軟で便利な治療オプションを患者に記載しています。CAPDでは、患者さんは1日中手動で透析液の交換を行うことができるため、自由度が高く、治療を受けながら日常生活を続けることができます。APDは、夜間の透析液交換を機械で自動化することで、利便性をさらに高め、患者が睡眠中に治療を受けられるようにします。CAPDとAPDの需要は、安定した継続的な毒素除去が可能なため、血液化学的状態がより安定し、全身の健康状態が改善されることにあります。また、これらの技術は、透析センターへの頻繁な通院の必要性を最小限に抑え、患者の日常生活への支障を軽減します。さらに、CAPDとAPDは在宅医療に適しており、個別化医療と遠隔モニタリングの増加傾向に合致しています。患者は自宅でこれらの手技を行うためのトレーニングを受けることができ、治療に対する権限委譲とコントロールの感覚を得ることができます。患者や医療プロバイダーがCAPDやAPDの利点をますます認識するようになるにつれて、これらの技術に対する需要が高まることが予想されます。その結果、腹膜透析技術のさらなる調査や技術革新が促進され、これらの方法を選択する患者のためのトレーニングプログラムやサポートサービスが拡大することで、市場の成長が促進されます。

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 世界の透析市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳:タイプ別

  • 血液透析
    • 市場動向
    • 主要セグメント
      • 従来型血液透析
      • 短時間血液透析
      • 夜間血液透析
    • 市場予測
  • 腹膜透析
    • 市場動向
    • 主要セグメント
      • 持続的外来腹膜透析(CAPD)
      • 自動腹膜透析(APD)
    • 市場予測

第7章 市場内訳:製品サービス別

  • サービス別
  • 機器
    • 市場動向
    • 主要セグメント
      • 透析装置
      • 水処理システム
      • その他
    • 市場予測
  • 消耗品
    • 市場動向
    • 主要セグメント
      • 透析装置
      • カテーテル
      • その他
    • 市場予測
  • 透析薬

第8章 市場内訳:エンドユーザー別

  • 施設内透析
  • 在宅透析

第9章 市場内訳:地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳:国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Asahi Kasei Corporation
    • B. Braun Melsungen AG
    • Baxter International Inc.
    • Becton Dickinson and Company
    • DaVita Inc.
    • Fresenius Medical Care AG & Co. KGaA
    • JMS Co. Ltd.
    • Medtronic plc
    • Nikkiso Co. Ltd.
    • NIPRO Corporation
    • Satellite Healthcare Inc.
    • Toray Industries Inc.
図表

List of Figures

  • Figure 1: Global: Dialysis Market: Major Drivers and Challenges
  • Figure 2: Global: Dialysis Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Dialysis Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Dialysis Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Dialysis Market: Breakup by Product and Services (in %), 2023
  • Figure 6: Global: Dialysis Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Dialysis Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Dialysis (Hemodialysis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Dialysis (Hemodialysis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Dialysis (Peritoneal Dialysis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Dialysis (Peritoneal Dialysis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Dialysis (Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Dialysis (Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Dialysis (Equipment) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Dialysis (Equipment) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Dialysis (Consumables) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Dialysis (Consumables) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Dialysis (Dialysis Drugs) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Dialysis (Dialysis Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Dialysis (In-center Dialysis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Dialysis (In-center Dialysis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Dialysis (Home Dialysis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Dialysis (Home Dialysis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: North America: Dialysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: North America: Dialysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: United States: Dialysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: United States: Dialysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Canada: Dialysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Canada: Dialysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Asia-Pacific: Dialysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Asia-Pacific: Dialysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: China: Dialysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: China: Dialysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Japan: Dialysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Japan: Dialysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: India: Dialysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: India: Dialysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: South Korea: Dialysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: South Korea: Dialysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Australia: Dialysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Australia: Dialysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Indonesia: Dialysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Indonesia: Dialysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Others: Dialysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Others: Dialysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Europe: Dialysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Europe: Dialysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Germany: Dialysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Germany: Dialysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: France: Dialysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: France: Dialysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: United Kingdom: Dialysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: United Kingdom: Dialysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Italy: Dialysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Italy: Dialysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Spain: Dialysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Spain: Dialysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Russia: Dialysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Russia: Dialysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Others: Dialysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Others: Dialysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Latin America: Dialysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Latin America: Dialysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Brazil: Dialysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Brazil: Dialysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Mexico: Dialysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Mexico: Dialysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Others: Dialysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Others: Dialysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Middle East and Africa: Dialysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Middle East and Africa: Dialysis Market: Breakup by Country (in %), 2023
  • Figure 72: Middle East and Africa: Dialysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Global: Dialysis Industry: SWOT Analysis
  • Figure 74: Global: Dialysis Industry: Value Chain Analysis
  • Figure 75: Global: Dialysis Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Dialysis Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Dialysis Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Dialysis Market Forecast: Breakup by Product and Services (in Million US$), 2024-2032
  • Table 4: Global: Dialysis Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Dialysis Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Dialysis Market: Competitive Structure
  • Table 7: Global: Dialysis Market: Key Players
目次
Product Code: SR112024A5940

The global dialysis market size reached US$ 115.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 170.4 Billion by 2032, exhibiting a growth rate (CAGR) of 4.3% during 2024-2032. The increasing availability of reimbursement policies for dialysis treatments, the rising number of kidney transplant patients requiring post-operative dialysis, and the growing focus on early diagnosis and intervention for kidney diseases are some of the factors propelling the market.

Dialysis is a crucial renal replacement therapy for individuals whose kidneys cannot function naturally. This medical procedure plays a vital role in eliminating toxins, excess water, salts, and solutes from the patient's bloodstream, effectively restoring a healthier balance. The primary objective of dialysis is to purify the blood and restore proper electrolyte levels within the body. This therapy comes in two main forms: hemodialysis and peritoneal dialysis. Hemodialysis involves the external purification of blood, a process that occurs outside the body. This technique effectively cleanses the blood of impurities, helping patients regain stability. On the other hand, peritoneal dialysis relies on the peritoneum, a lining within the abdomen, to purify the blood. By utilizing the peritoneum as a dialysis medium, this method offers an internal approach to blood cleansing. Both hemodialysis and peritoneal dialysis are instrumental in treating various kidney-related conditions. These treatments are commonly employed for addressing acute renal injuries, managing chronic kidney diseases, supporting kidney transplant procedures, or serving as a permanent solution when transplantation is not a viable option. The significance of dialysis cannot be overstated, as it significantly enhances the quality of life for individuals grappling with kidney dysfunctions. Through careful implementation and ongoing advancements in medical technology, dialysis continues to serve as a lifeline for patients needing renal support.

The global market is majorly driven by the increasing prevalence of chronic kidney diseases. In line with this, the rising aging population prone to kidney-related issues is significantly contributing to the market. Furthermore, the growing awareness about renal health and available treatment options is positively influencing the market. Apart from this, the rapid technological advancements leading to more efficient dialysis procedures are offering numerous opportunities for the market. Moreover, the heavy investments in research and development of innovative dialysis techniques are catalyzing the market. Besides, the higher incidence of diabetes, a major contributor to kidney diseases, is propelling the demand for dialysis. Additionally, the expansion of healthcare infrastructure in developing regions is providing a boost to the market. The escalating demand for home-based dialysis solutions is strengthening the market.

Dialysis Market Trends/Drivers:

Increasing lifestyle changes lead to kidney complications

The escalating trend of lifestyle changes is stimulating the market. Modern lifestyles characterized by poor dietary habits, sedentary routines, and high-stress levels contribute to a rise in kidney complications. Unhealthy diets rich in processed foods, high salt content, and inadequate hydration can lead to chronic conditions such as hypertension and diabetes, which are major causes of kidney diseases. The correlation between lifestyle factors and kidney complications has prompted an upswing in the prevalence of chronic kidney diseases. This rise in kidney-related issues has subsequently increased the demand for dialysis treatments, as affected individuals require renal replacement therapy to maintain their quality of life. The expanding patient pool necessitates the expansion of dialysis services, further driving the growth of the dialysis market. Consequently, healthcare providers, medical device manufacturers, and researchers are motivated to develop innovative solutions and strategies to address this growing demand and offer effective dialysis interventions.

Expansion of private dialysis clinics and centers

The expansion of private dialysis clinics and centers is bolstering the market. These private facilities offer several key advantages that contribute to their impact on market expansion. Private clinics often provide specialized and personalized care tailored to the unique needs of individual patients. This level of customization enhances patient satisfaction and outcomes, attracting a larger clientele and boosting market demand. Furthermore, private dialysis centers tend to offer more flexible scheduling options, accommodating patients' preferences and routines. This convenience factor attracts individuals seeking treatments that align with their busy lifestyles. Moreover, the establishment of private clinics fosters healthy competition within the market. This competition encourages innovation in treatment methodologies, technology adoption, and patient services, ultimately leading to improved quality of care across the industry. Additionally, private facilities are often well-equipped with the latest dialysis machines, technologies, and skilled medical personnel, ensuring efficient and effective treatments. This high standard of care helps build trust among patients and referring physicians, further driving patient referrals and market growth. Private dialysis clinics contribute to reducing the burden on public healthcare systems by providing alternative options for patients seeking dialysis services. This aspect is particularly crucial in regions with limited public resources, as private centers can alleviate strain on the healthcare infrastructure.

Rising demand for continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD)

The escalating demand for Continuous Ambulatory Peritoneal Dialysis (CAPD) and Automated Peritoneal Dialysis (APD) is fueling the market growth. These advanced peritoneal dialysis techniques offer numerous advantages that contribute to their increasing popularity. CAPD and APD provide patients with more flexible and convenient treatment options than traditional in-center hemodialysis. CAPD allows patients to perform manual exchanges of dialysate fluid throughout the day, offering greater freedom and the ability to continue daily activities while undergoing treatment. APD takes convenience a step further by utilizing a machine to automate dialysate exchanges at night, allowing patients to receive treatment while they sleep. The demand for CAPD and APD is driven by their ability to provide steady and continuous toxin removal, leading to more stable blood chemistry and improved overall health. These techniques also minimize the need for frequent visits to a dialysis center, reducing the disruption to patients' daily lives. Furthermore, CAPD and APD are well-suited for home-based care, aligning with the growing trend towards personalized healthcare and remote monitoring. Patients can receive training to perform these procedures at home, giving them a sense of empowerment and control over their treatment. As patients and healthcare providers increasingly recognize the benefits of CAPD and APD, the demand for these techniques is expected to rise. This, in turn, drives market growth by encouraging further research and innovation in peritoneal dialysis technology, as well as the expansion of training programs and support services for patients opting for these methods.

Dialysis Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global dialysis market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on type, product and services, and end user.

Breakup by Type:

Hemodialysis

Conventional Hemodialysis

Short Daily Hemodialysis

Nocturnal Hemodialysis

Peritoneal Dialysis

Continuous Ambulatory Peritoneal Dialysis (CAPD)

Automated Peritoneal Dialysis (APD)

Hemodialysis dominates the market

The report has provided a detailed breakup and analysis of the market based on the type. This includes hemodialysis (conventional hemodialysis, short daily hemodialysis, and nocturnal hemodialysis) and peritoneal dialysis (continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD)). According to the report, hemodialysis represented the largest segment.

Hemodialysis, a prominent renal replacement therapy, exerts substantial influence due to its widespread adoption and several associated factors. Its efficacy in rapidly removing toxins, excess fluids, and waste products from the bloodstream addresses critical medical needs in patients with kidney dysfunction. As a result, its demand is driven by the growing prevalence of chronic kidney diseases, kidney failures, and related conditions. The continuous advancement of hemodialysis technology has improved treatment outcomes and enhanced patient experiences.

Innovations such as high-efficiency dialyzers, vascular access techniques, and online monitoring systems have made hemodialysis more effective, comfortable, and accessible. Moreover, establishing specialized hemodialysis centers and integrating telehealth solutions has widened the reach of this treatment, making it accessible to more patients, including those in remote areas. These factors combined contribute to the segment's pivotal role in driving overall market growth as the demand for efficient renal replacement therapies rises.

Breakup by Product and Services:

Services

Equipment

Dialysis Machines

Water Treatment Systems

Others

Consumables

Dialyzers

Catheters

Others

Dialysis Drugs

Services dominates the market

The report has provided a detailed breakup and analysis of the market based on the product and services. This includes services, equipment (dialysis machines, water treatment systems, and others), consumables (dialyzers, catheters, and others), and dialysis drugs. According to the report, services represented the largest segment.

The services segment is vital in driving market growth within the dialysis industry. This segment encompasses a range of essential offerings that directly impact patient care, treatment accessibility, and overall industry expansion. Medical service providers, including healthcare professionals and specialized dialysis clinics, contribute significantly to the growth of this segment. These services encompass various aspects of patient care, from initial diagnosis and treatment planning to ongoing monitoring and support. The availability of high-quality medical services is crucial in attracting patients to seek timely interventions for kidney-related issues.

Furthermore, the services segment includes patient education and awareness initiatives. These programs empower patients with knowledge about kidney health, available treatment options, and self-care practices. By raising awareness and promoting early intervention, these educational efforts contribute to higher demand for dialysis services. The expansion of telehealth services is also a driving factor. Remote monitoring and consultation services enable patients to access medical guidance without frequent in-person visits, making dialysis care more convenient and efficient.

Breakup by End User:

In-center Dialysis

Home Dialysis

In-center dialysis dominates the market

The report has provided a detailed breakup and analysis of the market based on the end user. This includes in-center dialysis and home dialysis. According to the report, in-center dialysis represented the largest segment.

The in-center dialysis segment is a key driver of market growth within the dialysis industry. This segment caters to a substantial portion of the patient population, contributing significantly to the demand for dialysis services. In-center dialysis refers to treatments conducted within specialized dialysis centers or clinics under the supervision of trained medical professionals. This setting offers various advantages, including access to advanced medical equipment, close monitoring by healthcare staff, and the opportunity for patients to interact with peers facing similar health challenges.

The convenience and comprehensive care provided by in-center dialysis centers attract patients who require regular and closely supervised treatments. This includes individuals with advanced kidney diseases, complex medical histories, or those who benefit from personalized care plans. Moreover, in-center dialysis centers often house cutting-edge technology and skilled healthcare teams, ensuring high-quality treatment delivery. Patients appreciate the structured environment, professional support, and regular check-ins that in-center dialysis provides.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

With its well-established healthcare infrastructure, North America is at the forefront of adopting and implementing innovative dialysis technologies and treatment methodologies. This region's focus on research and development fosters continuous advancements in dialysis machines, equipment, and treatment protocols, enhancing the overall quality of patient care. The increasing prevalence of chronic kidney diseases, often associated with lifestyle factors such as obesity and diabetes, drives the demand for dialysis services in North America. A significant aging population also contributes to the rising need for renal replacement therapies.

Government initiatives, reimbursement policies, and awareness campaigns further promote early diagnosis and intervention for kidney-related issues, boosting the utilization of dialysis treatments. Additionally, the concentration of leading dialysis companies and medical research institutions in North America fuels the development and dissemination of state-of-the-art dialysis solutions.

Competitive Landscape:

Top companies are playing a crucial role in fostering the growth of the dialysis market through strategic initiatives and innovations. Armed with their extensive resources and expertise, these companies are driving market expansion in several ways. They invest heavily in research and development, leading to the creation of advanced dialysis technologies and treatment methods. This continuous innovation improves dialysis's efficacy, efficiency, and patient experience, enticing more individuals to opt for these treatments. Moreover, these companies collaborate with healthcare providers and institutions, ensuring widespread access to their products and services. Such partnerships facilitate the integration of cutting-edge dialysis solutions into existing healthcare ecosystems, thus expanding the market reach. Additionally, top companies often engage in awareness campaigns to educate the medical community and the general public about kidney health and available treatment options. This educational effort drives early diagnosis and intervention, increasing the demand for dialysis services. Besides, their global presence and distribution networks enable them to bring advanced dialysis solutions to regions with limited access to healthcare infrastructure. This expansion into underserved areas contributes to market growth by catering to a wider patient demographic.

The report has provided a comprehensive analysis of the competitive landscape in the dialysis market. Detailed profiles of all major companies have also been provided.

Asahi Kasei Corporation

B. Braun Melsungen AG

Baxter International Inc.

Becton Dickinson and Company

DaVita Inc.

Fresenius Medical Care AG & Co. KGaA

JMS Co. Ltd.

Medtronic plc

Nikkiso Co. Ltd.

NIPRO Corporation

Satellite Healthcare Inc.

Toray Industries Inc.

Recent Developments:

Toray Industries Inc. developed Japan's first polymethyl methacrylate (PMMA) hollow fiber membrane-based hemodiafiltration device in November 2021, addressing the need for alternative materials and improved performance in artificial kidneys. The PMMA hemodiafiltration device offers excellent biocompatibility and uremic toxin removal, thereby contributing to better medical care for patients with renal failure.

In 2021, Becton Dickinson and Company received FDA clearance for the Pristine Long-Term Hemodialysis Catheter, which features a unique side-hole free symmetric Y-Tip design to address complications associated with traditional catheters.

Satellite Healthcare Inc. has introduced a new care model designed for individuals recently diagnosed with kidney disease requiring dialysis, named Kidney Care Connection (KCC) in 2022. KCC offers spacious patient rooms, a demonstration kitchen for learning about healthy meals, and the option to transition to home dialysis after a few weeks.

Key Questions Answered in This Report

  • 1. What was the size of the global dialysis market in 2023?
  • 2. What is the expected growth rate of the global dialysis market during 2024-2032?
  • 3. What are the key factors driving the global dialysis market?
  • 4. What has been the impact of COVID-19 on the global dialysis market?
  • 5. What is the breakup of the global dialysis market based on type?
  • 6. What is the breakup of the global dialysis market based on the product and services?
  • 7. What is the breakup of the global dialysis market based on the end user?
  • 8. What are the key regions in the global dialysis market?
  • 9. Who are the key players/companies in the global dialysis market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Dialysis Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Hemodialysis
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Conventional Hemodialysis
      • 6.1.2.2 Short Daily Hemodialysis
      • 6.1.2.3 Nocturnal Hemodialysis
    • 6.1.3 Market Forecast
  • 6.2 Peritoneal Dialysis
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Continuous Ambulatory Peritoneal Dialysis (CAPD)
      • 6.2.2.2 Automated Peritoneal Dialysis (APD)
    • 6.2.3 Market Forecast

7 Market Breakup by Product and Services

  • 7.1 Services
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Equipment
    • 7.2.1 Market Trends
    • 7.2.2 Key Segments
      • 7.2.2.1 Dialysis Machines
      • 7.2.2.2 Water Treatment Systems
      • 7.2.2.3 Others
    • 7.2.3 Market Forecast
  • 7.3 Consumables
    • 7.3.1 Market Trends
    • 7.3.2 Key Segments
      • 7.3.2.1 Dialyzers
      • 7.3.2.2 Catheters
      • 7.3.2.3 Others
    • 7.3.3 Market Forecast
  • 7.4 Dialysis Drugs
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by End User

  • 8.1 In-center Dialysis
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Home Dialysis
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Asahi Kasei Corporation
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 B. Braun Melsungen AG
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 SWOT Analysis
    • 14.3.3 Baxter International Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Becton Dickinson and Company
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 DaVita Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Fresenius Medical Care AG & Co. KGaA
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 JMS Co. Ltd.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Medtronic plc
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Nikkiso Co. Ltd.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 NIPRO Corporation
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Satellite Healthcare Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Toray Industries Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis